Menu

• Ask a Health Expert about OESOPHAGITIS
• Post Your Side Effect related to OESOPHAGITIS
• OESOPHAGITIS and FDA Warnings
• OESOPHAGITIS in Patients Wiki
• Report OESOPHAGITIS in Drug Side Effect Survey

OESOPHAGITIS side effect

What is OESOPHAGITIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Abatacept Side Effects Report #5649171-X
Health Professional from BRAZIL reported ABATACEPT problem on Feb 21, 2008. Female patient, 42 years of age, was diagnosed with crohn's disease and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . ABATACEPT dosage: unknown. During the same period patient was treated with MESALAMINE, FLUOXETINE, AMITRIPTYLINE, OMEPRAZOLE, PROPRANOLOL, LOPERAMIDE. Patient recovered.

Capecitabine Side Effects Report #5675120-4
CAPECITABINE problem was reported by a Physician from GERMANY on Mar 12, 2008. Female patient, 66 years of age, weighting 170.9 lb, was diagnosed with breast cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, stomatitis, . CAPECITABINE dosage: unknown. During the same period patient was treated with DOCETAXEL, EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient recovered.

Taxol Side Effects Report #5613757-9
Health Professional from JAPAN reported TAXOL problem on Jan 28, 2008. Male patient, 54 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient was hospitalized. Patient recovered.

Herceptin Side Effects Report #5614437-6
HERCEPTIN problem was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . HERCEPTIN dosage: 320 MG, QD. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5619121-0
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 30, 2008. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 10 MG/KG, QOW. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5620114-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, weighting 160.9 lb, was diagnosed with metastatic gastric cancer, hypotension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 10 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, IRINOTECAN, DOCETAXEL, DIGOXIN, ESMOLOL, LOPRESSOR, CALCIUM CARBONATE, DOCUSATE. Patient was hospitalized. Patient died on 01/20/2008.

Bevacizumab Side Effects Report #5625220-X
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 06, 2008. Male patient, weighting 160.9 lb, was diagnosed with metastatic gastric cancer, hypotension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 10 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, IRINOTECAN, DOCETAXEL, DIGOXIN, ESMOLOL, LOPRESSOR, CALCIUM CARBONATE, DOCUSATE. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5595276-1
AVASTIN problem was reported by a Physician from FRANCE on Jan 04, 2008. Female patient, weighting 130.1 lb, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . AVASTIN dosage: 280 MG, 1/WEEK. During the same period patient was treated with TAXOL, DEROXAT, ATARAX. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5599742-4
Health Professional from JAPAN reported TAXOL problem on Jan 16, 2008. Male patient, 54 years of age, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5601760-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 16, 2008. Male patient, weighting 160.9 lb, was diagnosed with metastatic gastric cancer, hypotension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 10 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, IRINOTECAN, DOCETAXEL, DIGOXIN, ESMOLOL, LOPRESSOR, CALCIUM CARBONATE, DOCUSATE. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5546310-6
Health Professional from UNITED STATES reported CETUXIMAB problem on Dec 03, 2007. Female patient, 51 years of age, weighting 167.6 lb, was diagnosed with nasopharyngeal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, pyrexia, staphylococcal infection, . CETUXIMAB dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Exjade Side Effects Report #5553649-7
EXJADE problem was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, 73 years of age, was diagnosed with iron overload and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . EXJADE dosage: unknown. Patient was hospitalized. Patient recovered.

Briplatin Side Effects Report #5506107-X
Physician from JAPAN reported BRIPLATIN problem on Oct 31, 2007. Male patient, 56 years of age, was diagnosed with oesophageal squamous cell carcinoma and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BRIPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient recovered.

Ibandronic Side Effects Report #5526765-3
IBANDRONIC ACID problem was reported by a Health Professional from UNITED KINGDOM on Nov 19, 2007. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with osteoporosis and was treated with IBANDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . IBANDRONIC ACID dosage: unknown. Patient recovered.


Fosamax Side Effects Report #5582564-8
Health Professional from UNITED STATES reported FOSAMAX problem on Mar 20, 2007. Female patient was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . FOSAMAX dosage: 70 MG/WKY/PO. Patient was hospitalized. Patient recovered.

Fosamax Side Effects Report #5583194-4
FOSAMAX problem was reported by a Health Professional from UNITED STATES on Nov 28, 2006. Female patient, 76 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . FOSAMAX dosage: 70 MG/WKY/PO. During the same period patient was treated with ACTONEL, DIOVAN, LIPITOR. Patient recovered.

Fosamax Side Effects Report #5585321-1
Physician from UNITED STATES reported FOSAMAX problem on June 18, 2007. Female patient was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . FOSAMAX dosage: unknown. Patient was hospitalized. Patient recovered.

Boniva Side Effects Report #5483966-0
BONIVA problem was reported by a Physician from GREECE on Oct 02, 2007. Female patient, 50 years of age, was diagnosed with osteoporosis and was treated with BONIVA. After drug was administered, patient experienced the following problems/side effects: oesophagitis, paratracheal lymphadenopathy, . BONIVA dosage: unknown. Patient recovered.

Doxorubicin Side Effects Report #5377449-6
Physician from UNITED STATES reported DOXORUBICIN problem on June 22, 2007. Female patient, weighting 139.0 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . DOXORUBICIN dosage: unknown. During the same period patient was treated with TRABECTEDIN, NORVASC, EFFEXOR, NEURONTIN, ATIVAN, COLACE, SENOKOT, DETROL. Patient was hospitalized. Patient recovered.


Paclitaxel Side Effects Report #5382149-2
PACLITAXEL problem was reported by a Health Professional from GERMANY on July 06, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . PACLITAXEL dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Paclitaxel Side Effects Report #5385151-X
Health Professional from GERMANY reported PACLITAXEL problem on July 10, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . PACLITAXEL dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5390005-9
EPIRUBICIN problem was reported by a Health Professional from GERMANY on July 17, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5400528-1
Physician from UNITED STATES reported BEVACIZUMAB problem on July 24, 2007. Female patient, weighting 158.0 lb, was diagnosed with squamous cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, pyrexia, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5377449-6
DOXORUBICIN problem was reported by a Physician from UNITED STATES on June 22, 2007. Female patient, weighting 139.0 lb, was diagnosed with ovarian cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . DOXORUBICIN dosage: unknown. During the same period patient was treated with TRABECTEDIN, NORVASC, EFFEXOR, NEURONTIN, ATIVAN, COLACE, SENOKOT, DETROL. Patient was hospitalized. Patient recovered.

Paclitaxel Side Effects Report #5382149-2
Health Professional from GERMANY reported PACLITAXEL problem on July 06, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . PACLITAXEL dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Paclitaxel Side Effects Report #5385151-X
PACLITAXEL problem was reported by a Health Professional from GERMANY on July 10, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . PACLITAXEL dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Epirubicin Side Effects Report #5390005-9
Health Professional from GERMANY reported EPIRUBICIN problem on July 17, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Bevacizumab Side Effects Report #5400528-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on July 24, 2007. Female patient, weighting 158.0 lb, was diagnosed with squamous cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, pyrexia, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Fluoxetine Side Effects Report #5763998-5
Physician from UNITED STATES reported FLUOXETINE problem on June 06, 2008. Female patient, weighting 109.4 lb, was diagnosed with obsessive-compulsive disorder and was treated with FLUOXETINE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . FLUOXETINE dosage: 20MG ONCE DAILY ORAL. During the same period patient was treated with CYCLESSA, PREVACID. Patient recovered.

Bevacizumab Side Effects Report #5766486-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on May 21, 2008. Male patient, weighting 139.0 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5774575-4
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on June 03, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5729649-0
VELCADE problem was reported by a Physician from BELGIUM on Apr 23, 2008. Female patient, 60 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . VELCADE dosage: 1.3 MG/M2. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5731555-2
Health Professional from UNITED STATES reported ERLOTINIB problem on Apr 22, 2008. Female patient, 61 years of age, weighting 220.0 lb, was diagnosed with tonsil cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, RADIATION, HYDROMORPHONE, HYPERALIMENTATION. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5738489-8
VELCADE problem was reported by a Health Professional from UNITED STATES on Apr 30, 2008. Male patient, 62 years of age, weighting 226.9 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . VELCADE dosage: 2.9 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXAN, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5750225-8
Physician from UNITED STATES reported BEVACIZUMAB problem on May 21, 2008. Male patient, weighting 139.0 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5751856-1
VELCADE problem was reported by a Physician from UNITED STATES on May 13, 2008. Male patient, 62 years of age, weighting 226.9 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . VELCADE dosage: 1.3 MG/M2, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXAN, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE, ACYCLOVIR, INSULIN GLARGINE, SULFAMETHOXAZOLE W. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5703518-4
Pharmacist from UNITED STATES reported BEVACIZUMAB problem on Apr 04, 2008. Male patient was diagnosed with oesophageal adenocarcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5709343-2
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Apr 03, 2008. Male patient, 68 years of age, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . AVASTIN dosage: 300 MG, Q2W. During the same period patient was treated with FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5346666-3
Health Professional from UNITED STATES reported BEVACIZUMAB problem on May 31, 2007. Female patient, 42 years of age, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 10 MG/KG, QOW. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5369557-0
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on June 06, 2007. Female patient, 42 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5314986-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Apr 24, 2007. Male patient was diagnosed with oesophageal adenocarcinoma, oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN, CISPLATIN, ALFUZOSIN HYDROCHLORIDE, ALPRAZOLAM, AMBIEN, ASPIRIN, ACIPHEX. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5326692-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on May 11, 2007. Male patient was diagnosed with oesophageal adenocarcinoma, oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . BEVACIZUMAB dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with IRINOTECAN, CISPLATIN, ALFUZOSIN HYDROCHLORIDE, ALPRAZOLAM, AMBIEN, ASPIRIN, ACIPHEX. Patient was hospitalized. Patient recovered.

Alkeran Side Effects Report #5326838-4
Consumer or non-health professional from ITALY reported ALKERAN problem on Apr 23, 2007. Female patient was diagnosed with multiple myeloma and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . ALKERAN dosage: 6 MG/M2 / PER DAY / ORAL. Patient recovered.

Carboplatin Side Effects Report #5333466-3
CARBOPLATIN problem was reported by a Physician from UNITED STATES on May 09, 2007. Female patient was diagnosed with oesophageal carcinoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, CAPECITABINE, RADIATION. Patient recovered.

Carboplatin Side Effects Report #5333467-5
Physician from UNITED STATES reported CARBOPLATIN problem on May 09, 2007. Female patient was diagnosed with oesophageal carcinoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, CAPECITABINE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5333468-7
CARBOPLATIN problem was reported by a Physician from UNITED STATES on May 09, 2007. Female patient was diagnosed with oesophageal carcinoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, CAPECITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5341046-9
Physician from UNITED STATES reported ERLOTINIB problem on May 14, 2007. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: oesophagitis, pulmonary haemorrhage, . ERLOTINIB dosage: 100 MG (4 TIMER PER WEEK), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5297281-1
GEMZAR problem was reported by a Physician from SPAIN on Apr 09, 2007. Female patient, 60 years of age, was diagnosed with malignant hepatobiliary neoplasm and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: oesophagitis, vomiting, . GEMZAR dosage: unknown. During the same period patient was treated with XELODA, CAPOTEN, OMEPRAZOLE, METAMIZOL, EMPORTAL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Xeloda Side Effects Report #5304374-9
Consumer or non-health professional from SPAIN reported XELODA problem on Apr 12, 2007. Male patient, 60 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: oesophagitis, vomiting, . XELODA dosage: unknown. During the same period patient was treated with GEMZAR, CAPOTEN, COLCHIMAX, OMEPRAZOLE, DIPYRONE, EMPORTAL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Nexium Side Effects Report #5312540-1
NEXIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Male patient, 53 years of age, weighting 200.0 lb, was diagnosed with erosive oesophagitis and was treated with NEXIUM. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . NEXIUM dosage: unknown. Patient recovered.

Fosamax Side Effects Report #5241336-4
Health Professional from UNITED STATES reported FOSAMAX PLUS D problem on Sept 15, 2006. Female patient, 89 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX PLUS D. After drug was administered, patient experienced the following problems/side effects: oesophagitis, . FOSAMAX PLUS D dosage: 70MG/2800 IU/WKY/PO. Patient was hospitalized. Patient recovered.